rather than a single toxin. This conclusion was based on their separation of two distinct activities by use of an NaCl gradient on a DEAESepharose CL-6B ion-exchange column. Toxin A, which eluted at a lower salt concentration than the second toxin, toxin B, was reported to be 17 times more lethal to animals but much less cytotoxic than toxin B (Taylor et al., Clin. Res. 28:285A, 1980) . In addition to these differences, antitoxin prepared against partially purified toxin A failed to neutralize the toxic effects of toxin B, suggesting that the two toxins are antigenically distinct. These investigators have not been able to produce antitoxin to toxin B.
To clarify the relationship between these two toxins, we produced antitoxins specific for both toxin A and toxin B to study the cross-reactions of these preparations with each other.
The toxins were prepared by growing C. difficile VPI 10463 at 37°C for 48 h inside dialysis tubing containing 100 ml of saline suspended in 2 liters of brain heart infusion broth as previously described (3, 9) . The contents of the dialysis tubing were then harvested by centrifugation at 8,000 x g for 10 min, followed by filtration with a 0.45-,m membrane filter. This culture filtrate was then diluted three times with 0.05 M Trishydrochloride, pH 7.5, in a thin-channel concentrator with an XM-100 filter (Amicon Corp., Lexington, Mass.). The retentate was finally concentrated to 5% of its original volume, and 35 ml of this preparation was applied to a DEAESepharose CL-6B ion-exchange column (2.5 by 8 cm). Toxin A was eluted from this column with a concentration gradient of 0.14 to 0.16 M NaCl. Toxin B was eluted from this column with a concentration gradient of 0.38 to 0.42 M NaCl. The partially purified toxin preparations were stored at 4°C until used.
Antitoxin to a mixture of partially purified toxins of C. difficile (anti-AB) was prepared in rabbits as previously described (9) an XM-100 ifiter. Toxoid was prepared from this preparation as previously described (9, 16) . Toxin A antitoxin (anti-A) was prepared in rabbits by the procedures previously described (9), with partially purified toxin A used for the preparation of the toxoid. Several attempts to produce antitoxin to toxin B (anti-B) by the same method failed. Antitoxin prepared to crude culture ifitrates of C. difficile, however, contained antibodies to both toxins. We thought that a similar preparation lacking only toxin A might result in the production of antibodies to toxin B (as well as other C. difficile extracellular proteins) but not to toxin A. We therefore prepared a toxoid with 1.0 ml of partially purified toxin B preparation added to 9.0 ml of a dialysis culture filtrate of C. difficile VPI 2037. This strain produces a large number of extracellular proteins but lacks both toxins, as determined by our cytotoxicity and mouse lethality assays. Rabbits injected with this preparation did produce anti-B.
The antitoxins were used first to test for crossreactivity in neutralization of the cytotoxicity of toxins A and B. The toxicity for tissue culture cells was determined from the percentage of cells (Chinese hamster ovary, CHO-K1) that became round on exposure to either toxin. The CHO-Ki cells were grown and the toxin titers were determined as previously described (9, 16) .
The TCD1oo was defined as the greatest dilution of toxin which would round 100%o of the CHOKl cells in a microtiter well (9 Toxicity in mice was determined by the number of mice (male ICR, 18 to 22 g; Flow Laboratories, Inc., Rockville, Md.) dead after intraperitoneal administration of 0.15 ml of twofold serial dilutions of either toxin (9) . The LD1oo was defined as the greatest dilution of toxin which would kill 100%o of the mice tested within 16 h.
We also tested whether there was any crossreactivity of the antitoxins in regard to protecting mice from the lethal effects of the toxins. Twofold serial dilutions of the antitoxins were mixed with the LD1oo of each toxin, and after incubation at room temperature for 1 h, 0.3 ml of each mixture was administered to mice by intraperitoneal injection. The titer of each antitoxin was determined to be the highest dilution of antitoxin at which all mice survived the LD100.
Mice were also passively immunized to determine whether in vivo neutralization would show any cross-reactivity. We thought that one toxin might be converted into the other in the animal. In two separate experiments, mice were administered 0.3 ml of the undiluted antitoxins by subcutaneous interscapular injection. At 2 or 6 h after this injection, each antitoxin group was divided and administered an LD100 of either toxin preparation by intraperitoneal injection. We have found that mice receiving a subcutaneous injection of 10-fold or greater dilutions of either antitoxin were not protected from the homologous toxin, and for this reason we administered the antitoxins at full strength. Control mice received either toxin preparation but had not been previously immunized with antitoxin.
The results of the first animal neutralization assay are given in Table 1 . Anti-A protected the mice from toxin A at a dilution of 1: 2,048 and appeared to neutralize toxin B to a very slight extent (1:16). Anti-B did not protect the mice from toxin A at any dilution tested but did protect the mice against toxin B. Neither anti-A nor anti-B protected mice effectively (titers of 1:4 and 1:32, respectively) from the lethal effects of the culture ifitrate containing both toxins, but anti-AB did protect the mice at a dilution of 1:256. Thus, neutralizing only one of the toxins did not protect the animals from death due to the culture filtrate injection except at high concentrations of the antitoxins; therefore, there is enough of either toxin in the culture filtrate to kill mice. This experiment provided the only evidence that we have observed suggesting a small amount of cross-reaction between these antitoxins and the nonhomologous toxins. A small degree of antigenic similarity may exist between these two toxins, although the data point to a greater degree of antigenic dissimilarity.
Of the mice receiving a subcutaneous injection of anti-A followed by Injecting antitoxin either 2 or 6 h before toxin administration made no difference to the survival of these animals.
Passive immunization of mice with specific 
